#Suvenlife those who want to learn more about SUVN-502 sub group analysis, please go through the press release and virtual conference...
https://drive.google.com/file/d/1LaGUUUQrGcJQsoFlFEOWgAzz7yxa4Eia/view?usp=sharing
https://drive.google.com/file/d/14tCHqrsT9qCP13CrqYthJOA1RGqotV2_/view?usp=sharing
My view -
- It has best pharmacological characteristics
- It was completely safe
https://drive.google.com/file/d/1LaGUUUQrGcJQsoFlFEOWgAzz7yxa4Eia/view?usp=sharing
https://drive.google.com/file/d/14tCHqrsT9qCP13CrqYthJOA1RGqotV2_/view?usp=sharing
My view -
- It has best pharmacological characteristics
- It was completely safe
- It was given in triple combination along with Memantine(Nameda) and Donepzile. In the absence of Memantine, the results would have been better. It also suggests, it works better than Memantine and possibly can replace it. Memantine is $1.5Bn drug in USA
- NPS (Neuro Psychiatric Scale) reading is much better measured by cognitive abilities, patient aggressiveness etc.
The data is analysed by third party experts mentioned in the press release
@AdityaKhemka5
The data is analysed by third party experts mentioned in the press release
@AdityaKhemka5